P

Policlinico Sant'Orsola-Malpighi | U.O. Oftalmologia Ciardella

Research site

(Unclaimed)

Location

Via Pelagio Palagi 9, Bologna, Bologna, Italy

Site insights

Top conditions

Top treatments

CC-5013

Lenalidomide

Azacitidine

Edoxaban

Palbociclib

Melphalan

Macitentan

Prednisone

Pexelizumab

RVU120

Parent organization

This site is a part of Policlinico Sant'Orsola-Malpighi

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 19 total trials

Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer (PATINA)

The primary objective of this study is to demonstrate that the combination of palbociclib with anti-HER2 therapy plus endocrine therapy is superior t...

Active, not recruiting

Estrogen Receptor Positive Breast Cancer

HER-2 Positive Breast Cancer

Drug: palbociclib

Drug: trastuzumab

Locations recently updated

RVU120 in Patients with Intermediate or High-risk, Primary or Secondary Myelofibrosis (POTAMI-61)

The objective of this clinical trial is to evaluate the efficacy (how well the drug works), safety, pharmacokinetics (PK), and pharmacodynamics (PD)...

Enrolling

Myelofibrosis

Drug: Ruxolitinib

Drug: RVU120